Royce & Associates LP Nevro Corp Transaction History

Royce & Associates LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$44.22 - $75.47 $1.02 Million - $1.74 Million	-23,000 Closed	0 $0
Q2 2018 Aug 09, 2018	SELL	$72.38 - $92.5 $940,939 - $1.2 Million	-13,000 Reduced 36.11%	23,000 $1.84 Million
Q4 2017 Feb 09, 2018	BUY	$65.94 - $93.31 $791,280 - $1.12 Million	12,000 Added 50.0%	36,000 $2.49 Million
Q3 2017 Nov 13, 2017	BUY	$80.87 - $91.08 $808,700 - $910,800	10,000 Added 71.43%	24,000 $2.18 Million
Q2 2017 Aug 07, 2017	BUY	N/A	14,000	14,000 $1.04 Million

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

Stay updated on Royce & Associates LP with notifications on news.